Cargando…

Stat5 Exerts Distinct, Vital Functions in the Cytoplasm and Nucleus of Bcr-Abl(+) K562 and Jak2(V617F)(+) HEL Leukemia Cells

Signal transducers and activators of transcription (Stats) play central roles in the conversion of extracellular signals, e.g., cytokines, hormones and growth factors, into tissue and cell type specific gene expression patterns. In normal cells, their signaling potential is strictly limited in exten...

Descripción completa

Detalles Bibliográficos
Autores principales: Weber, Axel, Borghouts, Corina, Brendel, Christian, Moriggl, Richard, Delis, Natalia, Brill, Boris, Vafaizadeh, Vida, Groner, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381271/
https://www.ncbi.nlm.nih.gov/pubmed/25809097
http://dx.doi.org/10.3390/cancers7010503
_version_ 1782364422578110464
author Weber, Axel
Borghouts, Corina
Brendel, Christian
Moriggl, Richard
Delis, Natalia
Brill, Boris
Vafaizadeh, Vida
Groner, Bernd
author_facet Weber, Axel
Borghouts, Corina
Brendel, Christian
Moriggl, Richard
Delis, Natalia
Brill, Boris
Vafaizadeh, Vida
Groner, Bernd
author_sort Weber, Axel
collection PubMed
description Signal transducers and activators of transcription (Stats) play central roles in the conversion of extracellular signals, e.g., cytokines, hormones and growth factors, into tissue and cell type specific gene expression patterns. In normal cells, their signaling potential is strictly limited in extent and duration. The persistent activation of Stat3 or Stat5 is found in many human tumor cells and contributes to their growth and survival. Stat5 activation plays a pivotal role in nearly all hematological malignancies and occurs downstream of oncogenic kinases, e.g., Bcr-Abl in chronic myeloid leukemias (CML) and Jak2(V617F) in other myeloproliferative diseases (MPD). We defined the mechanisms through which Stat5 affects growth and survival of K562 cells, representative of Bcr-Abl positive CML, and HEL cells, representative for Jak2(V617F) positive acute erythroid leukemia. In our experiments we suppressed the protein expression levels of Stat5a and Stat5b through shRNA mediated downregulation and demonstrated the dependence of cell survival on the presence of Stat5. Alternatively, we interfered with the functional capacities of the Stat5 protein through the interaction with a Stat5 specific peptide ligand. This ligand is a Stat5 specific peptide aptamer construct which comprises a 12mer peptide integrated into a modified thioredoxin scaffold, S5-DBD-PA. The peptide sequence specifically recognizes the DNA binding domain (DBD) of Stat5. Complex formation of S5-DBD-PA with Stat5 causes a strong reduction of P-Stat5 in the nuclear fraction of Bcr-Abl-transformed K562 cells and a suppression of Stat5 target genes. Distinct Stat5 mediated survival mechanisms were detected in K562 and Jak2(V617F)-transformed HEL cells. Stat5 is activated in the nuclear and cytosolic compartments of K562 cells and the S5-DBD-PA inhibitor most likely affects the viability of Bcr-Abl(+) K562 cells through the inhibition of canonical Stat5 induced target gene transcription. In HEL cells, Stat5 is predominantly present in the cytoplasm and the survival of the Jak2(V617F)(+) HEL cells is impeded through the inhibition of the cytoplasmic functions of Stat5.
format Online
Article
Text
id pubmed-4381271
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-43812712015-05-04 Stat5 Exerts Distinct, Vital Functions in the Cytoplasm and Nucleus of Bcr-Abl(+) K562 and Jak2(V617F)(+) HEL Leukemia Cells Weber, Axel Borghouts, Corina Brendel, Christian Moriggl, Richard Delis, Natalia Brill, Boris Vafaizadeh, Vida Groner, Bernd Cancers (Basel) Article Signal transducers and activators of transcription (Stats) play central roles in the conversion of extracellular signals, e.g., cytokines, hormones and growth factors, into tissue and cell type specific gene expression patterns. In normal cells, their signaling potential is strictly limited in extent and duration. The persistent activation of Stat3 or Stat5 is found in many human tumor cells and contributes to their growth and survival. Stat5 activation plays a pivotal role in nearly all hematological malignancies and occurs downstream of oncogenic kinases, e.g., Bcr-Abl in chronic myeloid leukemias (CML) and Jak2(V617F) in other myeloproliferative diseases (MPD). We defined the mechanisms through which Stat5 affects growth and survival of K562 cells, representative of Bcr-Abl positive CML, and HEL cells, representative for Jak2(V617F) positive acute erythroid leukemia. In our experiments we suppressed the protein expression levels of Stat5a and Stat5b through shRNA mediated downregulation and demonstrated the dependence of cell survival on the presence of Stat5. Alternatively, we interfered with the functional capacities of the Stat5 protein through the interaction with a Stat5 specific peptide ligand. This ligand is a Stat5 specific peptide aptamer construct which comprises a 12mer peptide integrated into a modified thioredoxin scaffold, S5-DBD-PA. The peptide sequence specifically recognizes the DNA binding domain (DBD) of Stat5. Complex formation of S5-DBD-PA with Stat5 causes a strong reduction of P-Stat5 in the nuclear fraction of Bcr-Abl-transformed K562 cells and a suppression of Stat5 target genes. Distinct Stat5 mediated survival mechanisms were detected in K562 and Jak2(V617F)-transformed HEL cells. Stat5 is activated in the nuclear and cytosolic compartments of K562 cells and the S5-DBD-PA inhibitor most likely affects the viability of Bcr-Abl(+) K562 cells through the inhibition of canonical Stat5 induced target gene transcription. In HEL cells, Stat5 is predominantly present in the cytoplasm and the survival of the Jak2(V617F)(+) HEL cells is impeded through the inhibition of the cytoplasmic functions of Stat5. MDPI 2015-03-19 /pmc/articles/PMC4381271/ /pubmed/25809097 http://dx.doi.org/10.3390/cancers7010503 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Weber, Axel
Borghouts, Corina
Brendel, Christian
Moriggl, Richard
Delis, Natalia
Brill, Boris
Vafaizadeh, Vida
Groner, Bernd
Stat5 Exerts Distinct, Vital Functions in the Cytoplasm and Nucleus of Bcr-Abl(+) K562 and Jak2(V617F)(+) HEL Leukemia Cells
title Stat5 Exerts Distinct, Vital Functions in the Cytoplasm and Nucleus of Bcr-Abl(+) K562 and Jak2(V617F)(+) HEL Leukemia Cells
title_full Stat5 Exerts Distinct, Vital Functions in the Cytoplasm and Nucleus of Bcr-Abl(+) K562 and Jak2(V617F)(+) HEL Leukemia Cells
title_fullStr Stat5 Exerts Distinct, Vital Functions in the Cytoplasm and Nucleus of Bcr-Abl(+) K562 and Jak2(V617F)(+) HEL Leukemia Cells
title_full_unstemmed Stat5 Exerts Distinct, Vital Functions in the Cytoplasm and Nucleus of Bcr-Abl(+) K562 and Jak2(V617F)(+) HEL Leukemia Cells
title_short Stat5 Exerts Distinct, Vital Functions in the Cytoplasm and Nucleus of Bcr-Abl(+) K562 and Jak2(V617F)(+) HEL Leukemia Cells
title_sort stat5 exerts distinct, vital functions in the cytoplasm and nucleus of bcr-abl(+) k562 and jak2(v617f)(+) hel leukemia cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381271/
https://www.ncbi.nlm.nih.gov/pubmed/25809097
http://dx.doi.org/10.3390/cancers7010503
work_keys_str_mv AT weberaxel stat5exertsdistinctvitalfunctionsinthecytoplasmandnucleusofbcrablk562andjak2v617fhelleukemiacells
AT borghoutscorina stat5exertsdistinctvitalfunctionsinthecytoplasmandnucleusofbcrablk562andjak2v617fhelleukemiacells
AT brendelchristian stat5exertsdistinctvitalfunctionsinthecytoplasmandnucleusofbcrablk562andjak2v617fhelleukemiacells
AT morigglrichard stat5exertsdistinctvitalfunctionsinthecytoplasmandnucleusofbcrablk562andjak2v617fhelleukemiacells
AT delisnatalia stat5exertsdistinctvitalfunctionsinthecytoplasmandnucleusofbcrablk562andjak2v617fhelleukemiacells
AT brillboris stat5exertsdistinctvitalfunctionsinthecytoplasmandnucleusofbcrablk562andjak2v617fhelleukemiacells
AT vafaizadehvida stat5exertsdistinctvitalfunctionsinthecytoplasmandnucleusofbcrablk562andjak2v617fhelleukemiacells
AT gronerbernd stat5exertsdistinctvitalfunctionsinthecytoplasmandnucleusofbcrablk562andjak2v617fhelleukemiacells